Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Auditor change
|
|
Acorda Therapeutics, Inc. (ACOR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/10/2023 |
SC 13D/A
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP reports a 4.5% stake in Acorda Therapeutics, Inc. |
| 03/10/2023 |
SC 13D/A
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP reports a 7.4% stake in Acorda Therapeutics, Inc. |
| 01/23/2023 |
SC 13D/A
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP reports a 8.6% stake in Acorda Therapeutics, Inc. |
| 01/23/2019 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 10.1% stake in Acorda Therapeutics, Inc. |
| 01/08/2019 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 11.3% stake in Acorda Therapeutics, Inc. |
| 12/13/2018 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 12.4% stake in Acorda Therapeutics, Inc. |
| 10/11/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/23/2018 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 15.4% stake in Acorda Therapeutics, Inc. |
| 06/20/2018 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 16.5% stake in Acorda Therapeutics, Inc. |
| 02/28/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/31/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/28/2009 |
SC 13D/A
| MILLENCO, L.L.C. reports a 4% stake in Acorda Therapeutics, Inc. |
| 12/12/2008 |
SC 13D/A
| ACORDA THERAPEUTICS INC reports a 3.9% stake in Acorda Therapeutics, Inc. |
|
|